Asia Mixed as Investors Inspect China Data
Asia-Pacific markets were mixed Friday as investors parsed China’s exports-imports data for April, with focus also on impending trade talks between Beijing and Washington.In Japan, the Nikkei 225 leaped 574.70 points, or 1.6%, to 37,503.33.In Hong Kong, the Hang Seng gained 91.82 points, or 0.4%, to 22,867.74.CHINA In China, the CSI 300 let go of 6.74 points, or 0.2%, to 3,846.16. China’s exports surged as shipments to Southeast Asian countries soared, offsetting a sharp drop in outbound goods to the U.S. as prohibitive tariffs kicked in.Exports climbed 8.1% in U.S. dollar terms in April compared to the same month last year, official data showed, significantly outperforming the 1.9% increase forecast in a Reuters poll. Shipments to the U.S. plunged over 21%.China stocks, however, did not get a boost from the strong data as tariff worries weigh on investor sentiment. In other markets, In Korea, the Kospi index docked 2.21 points, or 0.1%, to 2,577.27In Singapore, the Straits Times Index recovered 27.94 points, or 0.7%, to 3,876.16.In Taiwan, the Taiex Index popped 371.64 points, or 1.8%, to 20,915.04In New Zealand, the NZX 50 regained 138.03 points, or 1.1%, to 12,605.07.In Australia, the ASX 200 gained 39.55 points, or 0.5%, to 8,231.20
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


